E-LIB Suche - Ergebnisse für: Yoon, D.-S.

1

NK-CELLS TRAFFIC TO THE BONE MARROW AS A POTENTIAL IMMUNOLO..:

Hong, J. ; Ramaswamy, R. ; Min, S....
Leukemia Research Reports. 21 (2024) - p. 100441 , 2024

Link: https://doi.org/10.1016/..

2

Comparing the efficacy of different methods of faecal micro..:

Lee, E.H. ; Lee, S.K. ; Cheon, J.H....
Journal of Hospital Infection. 131 (2023) - p. 234-243 , 2023

Link: https://doi.org/10.1016/..

3

P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOU..:

Vannucchi, A. ; Mesa, R. ; Gerds, A....
HemaSphere. 6 (2022) - p. 940-941 , 2022

Link: https://doi.org/10.1097/..

4

S180: RG6234, A NOVEL GPRC5D T-CELL ENGAGING BISPECIFIC ANT..:

Hasselbalch Riley, C. ; Hutchings, M. ; Yoon, S.-S....
HemaSphere. 6 (2022) - p. 81-82 , 2022

Link: https://doi.org/10.1097/..

5

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MM..:

Verstovsek, S. ; Vannucchi, A. ; Gerds, A....
HemaSphere. 6 (2022) - p. 96-97 , 2022

Link: https://doi.org/10.1097/..

6

PB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING TH..:

Delimpasi, S. ; Quach, H. ; Cavo, M....
HemaSphere. 6 (2022) - p. 1906-1907 , 2022

Link: https://doi.org/10.1097/..

7

P1125: CELESTIMO: A PHASE III TRIAL EVALUATING THE EFFICACY..:

Nastoupil, L. ; Morschhauser, F. ; Scholz, C. W....
HemaSphere. 6 (2022) - p. 1015-1016 , 2022

Link: https://doi.org/10.1097/..

8

P894: A PHASE II TRIAL TO EVALUATE THE EFFICACY OF DARATUMU..:

Byun, J. M. ; Min, C.-K. ; Kim, K....
HemaSphere. 6 (2022) - p. 785-786 , 2022

Link: https://doi.org/10.1097/..

9

P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN REL..:

Spencer, A. ; Moreau, P. ; Mateos, M.-V....
HemaSphere. 6 (2022) - p. 823-824 , 2022

Link: https://doi.org/10.1097/..

10

P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG-TERM ..:

Röth, A. ; Egyed, M. ; Ichikawa, S....
HemaSphere. 6 (2022) - p. 724-725 , 2022

Link: https://doi.org/10.1097/..

11

S173: T-CELL ACTIVATION AND MYELOMA CELL KILLING CONFIRM TH..:

Dekhtiarenko, I. ; Lelios, I. ; Attig, J....
HemaSphere. 6 (2022) - p. 74-75 , 2022

Link: https://doi.org/10.1097/..

12

Prognosis after neoadjuvant chemoradiation or chemotherapy ..:

Vos, E L ; Carr, R A ; Hsu, M...
British Journal of Surgery. 108 (2021) 11 - p. 1332-1340 , 2021

Link: https://doi.org/10.1093/..

13

Feasibility of Preoperative Dose-Painting Intensity Modulat..:

Zhang, M. ; Crago, A.M. ; Yoon, S.S...
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e4 , 2020

Link: https://doi.org/10.1016/..

14

Survival and Patterns of Failure in Oligometastatic Esophag..:

Hilal, L. ; Ku, G. ; Molena, D....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e623 , 2020

Link: https://doi.org/10.1016/..

15

MANAGING CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY ..:

Sehn, L.H. ; Assouline, S. ; Bartlett, N.L....
Hematological Oncology. 37 (2019) S2 - p. 310-311 , 2019

Link: https://doi.org/10.1002/..